IMCR

Immunocore Holdings plc

70.30 USD
+0.44 (+0.63%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Immunocore Holdings plc stock is up 0.46% since 30 days ago. The next earnings date is Feb 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
16 Jan 17:27 20 Dec, 2024 95.00 CALL 81 2
24 Jan 15:47 19 Apr, 2024 80.00 CALL 618 1001
30 Jan 15:10 19 Apr, 2024 65.00 PUT 226 5
30 Jan 16:11 19 Apr, 2024 65.00 PUT 83 5
30 Jan 18:10 16 Feb, 2024 65.00 PUT 400 32
01 Feb 15:11 19 Apr, 2024 80.00 CALL 429 1619
01 Feb 15:37 19 Apr, 2024 80.00 CALL 500 1619
01 Feb 17:47 20 Dec, 2024 70.00 CALL 30 6
01 Feb 18:15 16 Feb, 2024 60.00 CALL 18 206
09 Feb 16:24 16 Feb, 2024 60.00 CALL 38 199

About Immunocore Holdings plc

Immunocore Holdings plc engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. KIMMTRAK is in Phase I/II trials for patients with unresectable or metastatic uveal melanoma. The company's programs for infectious diseases include IMC-I109V, which is in a clinical trial in patients with chronic hepatitis B virus.